This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Pharmaceutical Lactose Market

Market Insights on Pharmaceutical Lactose covering sales outlook, demand forecast & up-to-date key trends

Pharmaceutical Lactose Market By Product Type (Beta-Lactose, Gamma-Lactose monohydrate, Amorphous lactose, Spray dried lactose) & Region - Forecast to 2021 - 2031

About the Pharmaceutical Lactose Report

Increased access to medication through generic drug production, development of new treatments for chronic diseases, increasing research and development spending, rising competition, and advent of new technologies are driving the pharmaceutical lactose market.

The ability to perform various functions such as modifying drug release, taste masking accelerates, and improving active pharmaceutical ingredient stability are the major factors fuelling the for demand of pharmaceutical lactose. In addition to this, increasing adoption of excipients to enhance drug solubility and improve bioavailability has amped up the demand for pharmaceutical lactose.

In its new study, consulting firm Future Market Insights (FMI) offers insights about key factors driving demand for pharmaceutical lactose market. The report tracks the global sales of pharmaceutical lactose market in 20+ high-growth markets. This report gives details of the prospective growing markets in the gummy vitamins market and what are the driving factors of the pharmaceutical lactose market.

Customize this Report

Let us know your requirement to get
100% FREE customization

How the Historical and Future Outlook of Pharmaceutical Lactose Market Compare?

Rising preference toward preventive healthcare globally is anticipated to increase the demand for pharmaceutical lactose over the forecast period. Rising investments by local and foreign players in the pharmaceutical manufacturing sector, specifically in developing economies such as Brazil and China is anticipated to have a positive influence on pharmaceutical lactose industry growth.

In the past few years the awareness regarding functions and health benefits associated with pharmaceutical lactose has increased across the globe, leading to the influx of new players. Key producers are focusing on launching innovative products as well as focusing on partnerships to increase the production capacity.

According to FMI’s analysis, pharmaceutical lactose market have grown at 3.5% CAGR between 2016 and 2020.

Inhalation lactose is an excipient of high functionality that is helpful for the consistent performance of dry powder inhalation and thus ultimately to the patient’s wellbeing. Key players, end users, suppliers and regulators are working deeply to understand the inhalation lactose benefits and to adopt a various manufacturing strategy based on statistical models and to provide precise regulatory framework for advancement in forecast period. The significance of inhalation lactose in DPI performance has attracted a great deal of regulatory attention and the inhalation lactose remains an attraction in the global pharmaceutical lactose market.

The aim for improving palatability in oral drugs have driven the growth of various formulations with improved acceptability and performance. In recent years, mouth dissolving tablets have received important demand, and the field has become a rapidly growing area in the pharmaceutical industry. By numerous conventional methods, such as wet granulation, molding, direct compression, spray drying, sublimation and freeze drying etc. mouth dissolving tablets can be prepared

Will Use Of 3D Models Enhance Precision In Pharmaceutical Lactose?

In the pharmaceutical industry it is possible to design and manufacture novel complex drug products by using advent of 3D printing technology. 3D printing allows the creation of reliable dosage forms for clinical use and offers the capability to tailor doses for specific users.

To embrace new opportunities, pharmaceutical lactose manufacturers are adopting 3D technology for developing lactose blends with sufficient flow, wetting and binding. Benefits such as early phase drug development, high dose flexibility, and enabling personalized medicine escalate the usage of 3D printing in pharmaceutical industry.

About 1% of the drugs that are investigated make it through testing and gain approval. However, new technology is being pursued which accommodates increased precision in drug discovery. The advantage of 3D models is that it permits higher predictability of toxicity and effectiveness of a particular drug before it moves into the clinical trial phase, which in turn can reduce the attrition rate of new drugs and also speed up the new drug discovery process.

Nandini Roy Choudhury
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Will Innovation In Drug Delivery Drive Pharmaceutical Lactose Market?

The advent of new treatments will create interest in unique forms of drug delivery. The trend of new biological treatments is expected to continue through 2021. With the growing demand for higher health standards across the globe, there is increasing realization that the treatment of moderate conditions using conventional patient centric dosages presents a lucrative market. Specifically in the niche area of topicals, with the new guidelines and changes in the industry, the requirement for consistent production of complex semi solids can be anticipated to grow.

Country-wise Insights

Why Spain is leading the Europe Pharmaceutical Lactose Market?

Spain is leading the Europe pharmaceutical lactose market. Government support for hospitality services and development of treatment molecules and drugs in the country is an important factor driving pharmaceutical lactose market in Spain. Private insurance sector and medic aim in Spain is active with support to the patients with financial aids for several disease treatment this will push the pharmaceutical lactose market in Spain.

What is Driving Pharmaceutical Lactose Sales in Mexico?

Mexico is expected to continue at its leading position in forecast period with estimated market share of 23.2% by end of 2031. Latin America has a relatively smaller market share for healthcare and pharmaceutical and is slowly moving up the pharmaceutical sector growth ladder with a focus on innovation and adoption of advanced technologies across numerous industries.

Mexico is a rapidly growing hub for medical technology in Latin America. It has been attracting foreign investments in the Latin America. Increased penetration of leading pharmaceutical companies and adoption of new oral drug technologies in Mexico is anticipated to drive pharmaceutical lactose market in the country.

Will India’s Pharmaceutical Lactose Market Grow Exponentially?

The India market is expected to rise at the fastest CAGR in South Asia pharmaceutical lactose market. India is anticipated to grow with CAGR 6.9% in forecast period. Increasing research and development by regional as well as international players in India is projected to push the healthcare industry results in boost to pharmaceutical lactose market in the country.

South Asian countries showcase lower price range for drugs as compared to other regions. Increasing average dollar spending by India and ASEAN countries is escalating demand of the drugs resulting in growth of pharmaceutical lactose market across the region.

Why is Demand for Pharmaceutical Lactose Is Growing in China?

China’s pharmaceutical lactose market is anticipated to grow at a CAGR of little below 6% through 2031. China’s initiatives such as streamlining its state-owned enterprise (SOE) sector and introducing new amendments to current foreign investment laws will go a long way in ensuring enhanced economic stability in the country. The adoption of new technologies and increased penetration of the biological tools along with increasing research and development funds in China are expected to drive the market for pharmaceutical lactose during the forecast period.

Why is U.S. leading North America Pharmaceutical Lactose Market?

The U.S. is dominating the pharmaceutical lactose market in North America with market share of 60.6% in 2021. The increasing product adoption and presence of a well-established pharmaceutical industry are the major reasons for driving pharmaceutical lactose market in U.S. Continuous updates and technological advancements in the customized biologicals and advanced drugs are current trends in the regional market.

Pharmaceutical Lactose Market Download Report Brochure

Category Wise

Why Α-Lactose Monohydrate Is The Top-Selling Product?

α-Lactose monohydrate is leading in terms of product type in the pharmaceutical lactose market with market share nearly 46% in 2021. The segment is expected to show significant growth in forecast period. In the pharmaceutical industry this type of lactose is used widely as an excipient in the production of solid dosage forms. In dry powder inhalers it is used as a carrier. The pharmaceutical products in which α-Lactose monohydrate used as a primary ingredient have higher shelf life as compared to other products in which rest of pharmaceutical lactose types used. 

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape for Pharmaceutical Lactose Market

The global pharmaceutical lactose market is witnessing a rise in competition as more and more market players belonging to the lactose industry are taking an interest in venturing in this B2B business model. The rising demand for pharmaceutical lactose is creating tremendous opportunities for market players manufacturing pharmaceutical lactose.

Due to rising competition in the pharmaceutical lactose market, key players are focusing on launching innovative new products of pharmaceutical lactose in the market to sustain the position in the pharmaceutical lactose market.

For instance-

  • In 2015, Meggle launched triple compound pharma grade lactose CombiLac®, specifically designed to ease oral solid dosage

The key players of pharmaceutical lactose are focusing on partnership and joint venture to expand their product portfolio as well as to strengthen their supply chain. The partnership help to increase the production capacity of pharmaceutical lactose as well as expand the geographical reach.

For instance-

  • In Aug 2020, Armor Pharma signed a partnership with Nordmann for expanding its product footprint. Nordmann, an international chemical distributor, is supplying the German market with pharmaceutical-grade lactose products from the French manufacturer Armor Pharma.

Some of the leading companies operating in the pharmaceutical lactose market are:

  • Ba'emek Advanced Technologies Ltd (Tnuva Group)
  • Hilmar Ingredients
  • Armor Pharma
  • Avantor, Inc.
  • Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
  • Lactose (India) Limited
  • DFE Pharma
  • Hoogwegt Groep B.V.
  • Merck KgaA
  • Kerry plc
  • Milei GmbH
  • BASF SE
  • MEGGLE Excipients & Technology

*The list is not exhaustive, and only for representational purposes. Full competitive intelligence with SWOT analysis available in the report.

Scope of the Pharmaceutical Lactose Report

Attribute

Details

Forecast Period

2021-2031

Historical Data Available for

2016-2020

Pharmaceutical Lactose Market Analysis

USD Million for value and Metric Tons for Volume

Key Regions Covered

North America, Latin America, Europe, East Asia, South Asia, Oceania Middle East & Africa

Key Countries Covered

US, Canada, Brazil, Mexico, Chile, Peru, Argentina, Rest of Latin America, Germany, France, Italy, U.K., Spain, BENELUX, Nordic, Poland, Russia, Rest of Europe, China, Japan, South Korea, India, Malaysia, Singapore, Indonesia, Thailand, Rest of South Asia, Australia, New Zealand, GCC Countries, South Africa, Turkey, North Africa, Central Africa, Rest of MEA

Key Segments Covered

Product Type

Key Companies Profiled

  • Ba'emek Advanced Technologies Ltd (Tnuva Group)
  • Hilmar Ingredients
  • Armor Pharma
  • Avantor, Inc.
  • Alpavit Käserei Champignon Hofmeister GmbH & Co. KG
  • Lactose (India) Limited
  • DFE Pharma
  • Hoogwegt Groep B.V.
  • Merck KgaA
  • Kerry plc
  • Milei GmbH
  • BASF SE
  • MEGGLE Excipients & Technology

Pharmaceutical Lactose Report Coverage

Market Forecast, brand share analysis, competition intelligence, DROT analysis, Market Dynamics and Challenges, Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Pharmaceutical Lactose Market by Category

Product Type

  • Β-Lactose
  • α-Lactose monohydrate
  • Amorphous lactose
  • Spray dried lactose

Region

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Middle East and Africa (MEA)
  • Oceania

Frequently Asked Questions

The South Asia market is expected to grow at above 6% CAGR in pharmaceutical lactose market during forecast period. Presence of several leading players and higher spending on drugs among consumers will enable growth in the market.

α-Lactose monohydrate is anticipated to continue dominating the pharmaceutical lactose market in terms of product through 2031. The demand for excipients is rising rapidly across the globe, α-Lactose monohydrate is primary ingredient in excipients due to which its use is further expected to rise in near future.

Some of the key players operating in the pharmaceutical lactose market are Avantor, Inc., Ba'emek Advanced Technologies Ltd (Tnuva Group), Koninklijke FrieslandCampina N.V., Armor Pharma, Hilmar Ingredients Inc., Hoogwegt Groep B.V., Kerry Group plc, Lactose (India) Limited, Merck KGaA, BASF SE, Milei GmbH, and other playes.

Key players in the pharmaceutical lactose market are focusing on launching high quality lactose products. Globally the number of new players entering in the market are growing due to which, completion is getting intense in the pharmaceutical lactose market.

Cloud-based technologies are being incorporated in the development of pharmaceutical lactose. Continuous developments in cloud-based drug discovery platforms are anticipated to contribute significantly towards the growth of the global market for pharmaceutical lactose.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Product Positioning Metrics

    4.2. Product Utilization in High-Growth End Use Applications

    4.3. Quality Certifications and Claims Impact Analysis

5. Global Pharmaceutical Lactose Market Demand Analysis 2016-2020 and Forecast, 2021-2031

    5.1. Historical Market Volume (Metric Tons) Analysis, 2016-2020

    5.2. Current and Future Market Volume (Metric Tons) Projections, 2021-2031

    5.3. Y-o-Y Growth Trend Analysis

6. Global Pharmaceutical Lactose Market - Pricing Analysis

    6.1. Regional Pricing Analysis (US$/Metric Tons) By Product

    6.2. Pricing Break-up

        6.2.1. Manufacturer Level Pricing

        6.2.2. Distributor Level Pricing

    6.3. Global Average Pricing Analysis Benchmark

7. Global Pharmaceutical Lactose Market Demand (Size in US$ Mn) Analysis 2016-2020 and Forecast, 2021-2031

    7.1. Historical Market Value (US$ Mn) Analysis, 2016-2020

    7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Market Background

    8.1. Policy Developments and Regulatory Scenario

    8.2. Supply/Demand and Trade Scenario

    8.3. Nutritional Composition of Pharmaceutical Lactose

    8.4. Macro-Economic Factors

        8.4.1. Global GDP Growth Outlook

        8.4.2. Global Industry Value Added

    8.5. Forecast Factors - Relevance & Impact

        8.5.1. Dairy Production Outlook

        8.5.2. Trade Tariffs and Regulation Outlook

        8.5.3. Production/Processing Capacity Growth

        8.5.4. Pharmaceutical Industry Outlook

    8.6. Value Chain Analysis

        8.6.1. % of Profit margin Analysis

        8.6.2. List of Active Market Participants

            8.6.2.1. Raw Material Suppliers

            8.6.2.2. Product Manufacturers

            8.6.2.3. End Users

    8.7. Market Dynamics

        8.7.1. Drivers

        8.7.2. Restraints

        8.7.3. Opportunity

9. Global Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031, By Product Type 

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) and Volume Analysis By Product Type, 2016-2020

    9.3. Current and Future Market Size (US$ Mn) and Volume Analysis and Forecast By Product Type, 2021-2031

        9.3.1. Β-Lactose 

        9.3.2. α-Lactose monohydrate

        9.3.3. Amorphous lactose

        9.3.4. Spray dried lactose 

    9.4. Market Attractiveness Analysis By Product Type

10. Global Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031, By Application 

    10.1. Introduction / Key Findings

    10.2. % of Demand Assessment

        10.2.1. Direct Compression

        10.2.2. Wet Granulation

        10.2.3. Dry Granulation

        10.2.4. Powder Preparations

        10.2.5. Dry Powder Inhalation

        10.2.6. Others

    10.3. Market Attractiveness Analysis By Application

11. Global Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031, By Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2016-2020

    11.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2021-2031

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa

    11.4. Market Attractiveness Analysis By Region

12. North America Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    12.1. Introduction

    12.2. Pricing Analysis

    12.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    12.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        12.4.1. By Country

            12.4.1.1. U.S.

            12.4.1.2. Canada

        12.4.2. By Product Type

    12.5. Market Share Analysis By Country, 2021

        12.5.1. U.S.

            12.5.1.1. By Product Type

        12.5.2. Canada

            12.5.2.1. By Product Type

    12.6. Market Attractiveness Analysis

        12.6.1. By Country

        12.6.2. By Product Type

    12.7. Market Trends

    12.8. Key Market Participants - Intensity Mapping

    12.9. Drivers and Restraints - Impact Analysis

13. Latin America Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        13.4.1. By Country

            13.4.1.1. Brazil

            13.4.1.2. Mexico

            13.4.1.3. Argentina

            13.4.1.4. Chile

            13.4.1.5. Peru

            13.4.1.6. Rest of Latin America

        13.4.2. By Product Type

    13.5. Market Share Analysis By Country, 2021

        13.5.1. Brazil

            13.5.1.1. By Product Type

        13.5.2. Mexico

            13.5.2.1. By Product Type

        13.5.3. Argentina

            13.5.3.1. By Product Type

        13.5.4. Chile

            13.5.4.1. By Product Type

        13.5.5. Peru

            13.5.5.1. By Product Type

    13.6. Market Attractiveness Analysis

        13.6.1. By Country

        13.6.2. By Product Type

    13.7. Market Trends

    13.8. Key Market Participants - Intensity Mapping

    13.9. Drivers and Restraints - Impact Analysis

14. Europe Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        14.4.1. By Country

            14.4.1.1. Germany

            14.4.1.2. Italy

            14.4.1.3. France

            14.4.1.4. U.K.

            14.4.1.5. Spain

            14.4.1.6. Russia

            14.4.1.7. Poland

            14.4.1.8. BENELUX

            14.4.1.9. Nordic

            14.4.1.10. Rest of Europe

        14.4.2. By Product Type

    14.5. Market Share Analysis By Country, 2021

        14.5.1. Germany

            14.5.1.1. By Product Type

        14.5.2. Italy

            14.5.2.1. By Product Type

        14.5.3. France

            14.5.3.1. By Product Type

        14.5.4. U.K.

            14.5.4.1. By Product Type

        14.5.5. Spain

            14.5.5.1. By Product Type

        14.5.6. Russia

            14.5.6.1. By Product Type

        14.5.7. Poland

            14.5.7.1. By Product Type

        14.5.8. BENELUX

            14.5.8.1. By Product Type

        14.5.9. Nordic

            14.5.9.1. By Product Type

    14.6. Market Attractiveness Analysis

        14.6.1. By Country

        14.6.2. By Product Type

    14.7. Market Trends

    14.8. Key Market Participants - Intensity Mapping

    14.9. Drivers and Restraints - Impact Analysis

15. East Asia Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        15.4.1. By Country

            15.4.1.1. China

            15.4.1.2. Japan

            15.4.1.3. South Korea

        15.4.2. By Product Type

    15.5. Market Share Analysis By Country, 2021

        15.5.1. China

            15.5.1.1. By Product Type

        15.5.2. Japan

            15.5.2.1. By Product Type

        15.5.3. South Korea

            15.5.3.1. By Product Type

    15.6. Market Attractiveness Analysis

        15.6.1. By Country

        15.6.2. By Product Type

    15.7. Market Trends

    15.8. Key Market Participants - Intensity Mapping

    15.9. Drivers and Restraints - Impact Analysis

16. South Asia Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    16.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        16.4.1. By Country

            16.4.1.1. India

            16.4.1.2. Thailand

            16.4.1.3. Indonesia

            16.4.1.4. Malaysia

            16.4.1.5. Singapore

            16.4.1.6. Rest of South Asia

        16.4.2. By Product Type

    16.5. Market Share Analysis By Country, 2021

        16.5.1. India

            16.5.1.1. By Product Type

        16.5.2. Thailand

            16.5.2.1. By Product Type

        16.5.3. Indonesia

            16.5.3.1. By Product Type

        16.5.4. Malaysia

            16.5.4.1. By Product Type

        16.5.5. Singapore

            16.5.5.1. By Product Type

    16.6. Market Attractiveness Analysis

        16.6.1. By Country

        16.6.2. By Product Type

    16.7. Market Trends

    16.8. Key Market Participants - Intensity Mapping

    16.9. Drivers and Restraints - Impact Analysis

17. Oceania Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    17.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        17.4.1. By Country

            17.4.1.1. Australia

            17.4.1.2. New Zealand

        17.4.2. By Product Type

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product Type

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

18. Middle East and Africa Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2016-2020

    18.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2021-2031

        18.4.1. By Country

            18.4.1.1. South Africa

            18.4.1.2. GCC Countries

            18.4.1.3. North Africa

            18.4.1.4. Central Africa

            18.4.1.5. Rest of Middle East and Africa

        18.4.2. By Product Type

    18.5. Market Share Analysis By Country, 2021

        18.5.1. South Africa

            18.5.1.1. By Product Type

        18.5.2. GCC Countries

            18.5.2.1. By Product Type

        18.5.3. North Africa

            18.5.3.1. By Product Type

        18.5.4. Central Africa

            18.5.4.1. By Product Type

    18.6. Market Attractiveness Analysis

        18.6.1. By Country

        18.6.2. By Product Type

    18.7. Market Trends

    18.8. Key Market Participants - Intensity Mapping

    18.9. Drivers and Restraints - Impact Analysis

19. Emerging Countries Pharmaceutical Lactose Market Analysis 2016-2020 and Forecast 2021-2031

    19.1. Introduction

        19.1.1. Market Value Proportion Analysis, By Key Countries

        19.1.2. Growth Comparison of Global Market v/s Emerging Countries

    19.2. China Pharmaceutical Lactose Market Analysis

        19.2.1. Introduction

        19.2.2. Pricing Analysis

        19.2.3. PEST Analysis

        19.2.4. Market Value Proportion Analysis by Market Taxonomy

        19.2.5. Market Volume (Metric Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            19.2.5.1. By Product Type

        19.2.6. China Pharmaceutical Lactose Market - Competition Landscape

        19.2.7. China - Trade Analysis

    19.3. India Pharmaceutical Lactose Market Analysis

        19.3.1. Introduction

        19.3.2. Pricing Analysis

        19.3.3. PEST Analysis

        19.3.4. Market Value Proportion Analysis by Market Taxonomy

        19.3.5. Market Volume (Metric Tons) and Value (US$ Mn) Analysis and Forecast by Market Taxonomy

            19.3.5.1. By Product Type

        19.3.6. India Pharmaceutical Lactose Market - Competition Landscape

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Company Share Analysis of Top Players

        20.2.1. By Product Type

        20.2.2. By Region

    20.3. Market Presence Analysis

        20.3.1. By Regional Footprint of Players

        20.3.2. Product Footprint by Players

        20.3.3. Channel Footprint by Players

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Deep pe (Tentative List)

        21.2.1. Alpavit Käserei Champignon Hofmeister GmbH & Co. KG

            21.2.1.1. Overview

            21.2.1.2. Product Portfolio

            21.2.1.3. Profitability by Market Segments (Product/Region)

            21.2.1.4. Sales Footprint

            21.2.1.5. Strategy Overview

        21.2.2. Armor Pharma

            21.2.2.1. Overview

            21.2.2.2. Product Portfolio

            21.2.2.3. Profitability by Market Segments (Product/Region)

            21.2.2.4. Sales Footprint

            21.2.2.5. Strategy Overview

        21.2.3. Avantor, Inc.

            21.2.3.1. Overview

            21.2.3.2. Product Portfolio

            21.2.3.3. Profitability by Market Segments (Product/Region)

            21.2.3.4. Sales Footprint

            21.2.3.5. Strategy Overview

        21.2.4. Ba'emek Advanced Technologies Ltd (Tnuva Group)

            21.2.4.1. Overview

            21.2.4.2. Product Portfolio

            21.2.4.3. Profitability by Market Segments (Product/Region)

            21.2.4.4. Sales Footprint

            21.2.4.5. Strategy Overview

        21.2.5. BASF SE

            21.2.5.1. Overview

            21.2.5.2. Product Portfolio

            21.2.5.3. Profitability by Market Segments (Product/Region)

            21.2.5.4. Sales Footprint

            21.2.5.5. Strategy Overview

        21.2.6. DFE Pharma (JV of Royal FrieslandCampina & Fonterra Ltd.)

            21.2.6.1. Overview

            21.2.6.2. Product Portfolio

            21.2.6.3. Profitability by Market Segments (Product/Region)

            21.2.6.4. Sales Footprint

            21.2.6.5. Strategy Overview

        21.2.7. Hilmar Ingredients

            21.2.7.1. Overview

            21.2.7.2. Product Portfolio

            21.2.7.3. Profitability by Market Segments (Product/Region)

            21.2.7.4. Sales Footprint

            21.2.7.5. Strategy Overview

        21.2.8. Hoogwegt Groep B.V.

            21.2.8.1. Overview

            21.2.8.2. Product Portfolio

            21.2.8.3. Profitability by Market Segments (Product/Region)

            21.2.8.4. Sales Footprint

            21.2.8.5. Strategy Overview

        21.2.9. Kerry plc

            21.2.9.1. Overview

            21.2.9.2. Product Portfolio

            21.2.9.3. Profitability by Market Segments (Product/Region)

            21.2.9.4. Sales Footprint

            21.2.9.5. Strategy Overview

        21.2.10. Lactose (India) Limited

            21.2.10.1. Overview

            21.2.10.2. Product Portfolio

            21.2.10.3. Profitability by Market Segments (Product/Region)

            21.2.10.4. Sales Footprint

            21.2.10.5. Strategy Overview

        21.2.11. Merck KgaA

            21.2.11.1. Overview

            21.2.11.2. Product Portfolio

            21.2.11.3. Profitability by Market Segments (Product/Region)

            21.2.11.4. Sales Footprint

            21.2.11.5. Strategy Overview

        21.2.12. Milei GmbH

            21.2.12.1. Overview

            21.2.12.2. Product Portfolio

            21.2.12.3. Profitability by Market Segments (Product/Region)

            21.2.12.4. Sales Footprint

            21.2.12.5. Strategy Overview

        21.2.13. MEGGLE Excipients & Technology

            21.2.13.1. Overview

            21.2.13.2. Product Portfolio

            21.2.13.3. Profitability by Market Segments (Product/Region)

            21.2.13.4. Sales Footprint

            21.2.13.5. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 02: Global Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 03: Global Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 04: Global Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 05: Global Pharmaceutical Lactose Historical Market Value (US$ Mn) by Region, 2016–2020

Table 06: Global Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Region, 2021–2031

Table 07: Global Pharmaceutical Lactose Historical Market Volume (Units) by Region, 2016–2020

Table 08: Global Pharmaceutical Lactose Forecast Market Volume (Units) by Region, 2021–2031

Table 09: North America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 010: North America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 11: North America Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 12: North America Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 13: North America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 14: North America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 15: North America Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 16: North America Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 17: Latin America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 18: Latin America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 19: Latin America Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 20: Latin America Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 21: Latin America Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 22: Latin America Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 23: Latin America Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 24: Latin America Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 25: Europe Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 26: Europe Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 27: Europe Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 28: Europe Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 29: Europe Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 30: Europe Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 31: Europe Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 32: Europe Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 33: East Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 34: East Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 35: East Asia Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 36: East Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 37: East Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 38: East Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 39: East Asia Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 40: East Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 41: South Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 42: South Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 43: South Asia Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 44: South Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 45: South Asia Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 46: South Asia Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 47: South Asia Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 48: South Asia Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 49: Oceania Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 50: Oceania Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 51: Oceania Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 52: Oceania Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 53: Oceania Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 54: Oceania Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 55: Oceania Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 56: Oceania Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Table 57: Middle East & Africa Pharmaceutical Lactose Historical Market Value (US$ Mn) by Country, 2016–2020

Table 58: Middle East & Africa Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Country, 2021–2031

Table 59: Middle East & Africa Pharmaceutical Lactose Historical Market Volume (Units) by Country, 2016–2020

Table 60: Middle East & Africa Pharmaceutical Lactose Forecast Market Volume (Units) by Country, 2021–2031

Table 61: Middle East & Africa Pharmaceutical Lactose Historical Market Value (US$ Mn) by Product Type, 2016–2020

Table 62: Middle East & Africa Pharmaceutical Lactose Forecast Market Value (US$ Mn) by Product Type, 2020-2030

Table 63: Middle East & Africa Pharmaceutical Lactose Historical Market Volume (Units) by Product Type 2016–2020

Table 64: Middle East & Africa Pharmaceutical Lactose Forecast Market Volume (Units) by Product Type, 2021–2031

Nandini Roy Choudhury
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst
List of Charts

Figure 01: Global Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 02: Global Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 03: Global Pharmaceutical Lactose Market by Β-Lactose Value (US$ Mn), Volume (MT) and Forecast, 2016-2031

Figure 04: Global Pharmaceutical Lactose Market by Β-Lactose Incremental $ Opportunity, 2020-2031

Figure 05: Global Pharmaceutical Lactose Market By α-Lactose monohydrate Value (US$ Mn), Volume (MT) and Forecast

Figure 06: Global Pharmaceutical Lactose Market By α-Lactose monohydrate Incremental $ Opportunity, 2020-2031

Figure 07: Global Pharmaceutical Lactose Market by Amorphous lactose Value (US$ Mn), Volume (MT) and Forecast, 2016-2031

Figure 08: Global Pharmaceutical Lactose Market by Amorphous Lactose Incremental $ Opportunity, 2020-2031

Figure 09: Global Pharmaceutical Lactose Market by Spray dried lactose Value (US$ Mn), Volume (MT) and Forecast, 2016-2031

Figure 10: Global Pharmaceutical Lactose Market by Spray dried lactose Incremental $ Opportunity, 2020-2031

Figure 11: Global Pharmaceutical Lactose Market Value Share (%) and BPS Analysis by Region, 2021 & 2031

Figure 12: Global Pharmaceutical Lactose Market Y-o-Y Growth (%) Projections by Segment, 2021-2031

Figure 13: North America Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 14: Latin America Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 15: Europe Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 16: East Asia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 17: South Asia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 18: Oceania Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 19: Middle East & Africa Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 20: Global Pharmaceutical Lactose Market Attractiveness Analysis by Region, 2021-2031

Figure 21: North America Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 22: North America Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 23: North America Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Figure 24: U.S. Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 25: Canada Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 26: US Market Share Analysis by Product Type, 2021

Figure 27: Canada Market Share Analysis by Product Type, 2021

Figure 28: North America Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 29: North America Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 30: Latin America Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 31: Latin America Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 32: Latin America Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Figure 33: Brazil Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 34: Mexico Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 35: Chile Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 36: Peru Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 37: Argentina Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 38: Rest of LATAM Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 39: Brazil Market Share Analysis by Product Type, 2021

Figure 40: Mexico Market Share Analysis by Product Type, 2021

Figure 41: Argentina Market Share Analysis by Product Type, 2021

Figure 42: Chile Market Share Analysis by Product Type, 2021

Figure 43: Peru Market Share Analysis by Product Type, 2021

Figure 44: Latin America Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 45: Latin America Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 46: Europe Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 47: Europe Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 48: Europe Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Figure 49: Poland Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 50: Germany Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 51: Italy Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 52: Spain Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 53: France Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 54: UK Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 55: BENELUX Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 56: Nordic Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 57: Russia Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 58: Rest of Europe Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 59: Poland Market Share Analysis by Product Type, 2021

Figure 60: Germany Market Share Analysis by Product Type, 2021

Figure 61: Italy Market Share Analysis by Product Type, 2021

Figure 62: Spain Market Share Analysis by Product Type, 2021

Figure 63: France Market Share Analysis by Product Type, 2021

Figure 64: UK Market Share Analysis by Product Type, 2021

Figure 65: BENELUX Market Share Analysis by Product Type, 2021

Figure 66: Nordic Market Share Analysis by Product Type, 2021

Figure 67: Russia Market Share Analysis by Product Type, 2021

Figure 68: Rest of Europe Market Share Analysis by Product Type, 2021

Figure 69: Europe Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 70: Europe Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 71: East Asia Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 72: East Asia Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 73: East Asia Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Figure 74: China Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 75: Japan Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 76: South Korea Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 77: China Market Share Analysis by Product Type, 2021

Figure 78: Japan Market Share Analysis by Product Type, 2021

Figure 79: South Korea Market Share Analysis by Product Type, 2021

Figure 80: East Asia Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 81: East Asia Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 82: South Asia Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 83: South Asia Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 84: South Asia Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Figure 85: Indonesia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 86: Malaysia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 87: Singapore Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 88: India Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 89: Thailand Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 90: Rest of South Asia Pharmaceutical Lactose Absolute $ Opportunity Analysis, 2021-2031

Figure 91: Indonesia Market Share Analysis by Product Type, 2021

Figure 92: Malaysia Market Share Analysis by Product Type, 2021

Figure 93: Singapore Market Share Analysis by Product Type, 2021

Figure 94: India Market Share Analysis by Product Type, 2021

Figure 95: Thailand Market Share Analysis by Product Type, 2021

Figure 96: South Asia Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 97: South Asia Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 98: Oceania Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 99: Oceania Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 100: Oceania Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Figure 101: Australia Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 102: New Zealand Pharmaceutical Lactose Market Incremental $ Opportunity, 2021-2031

Figure 103: Australia Market Share Analysis by Product Type, 2021

Figure 104: New Zealand Market Share Analysis by Product Type, 2021

Figure 105: Oceania Pharmaceutical Lactose Market Share and BPS Analysis by Product Type– 2021 & 2031

Figure 106: Oceania Pharmaceutical Lactose Market Attractiveness Analysis by Product Type, 2021-2031

Figure 107: MEA Pharmaceutical Lactose Market Value (US$ Mn), Volume (Tons) Forecast and Analysis, 2021-2031

Figure 108: MEA Pharmaceutical Lactose Market Share and BPS Analysis by Country, 2021 & 2031

Figure 109: MEA Pharmaceutical Lactose Market Attractiveness Analysis Country, 2021-2031

Need specific information?

Request Customization

Explore Food and Beverage Insights

View Reports
Google translate

Pharmaceutical Lactose Market